Can a smartphone app and smart blood pressure cuff save heart shock patients?
NCT ID NCT07085221
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a digital platform that monitors blood pressure and symptoms at home can improve outcomes for people with early cardiogenic shock, a serious heart condition. About 472 patients will be split into two groups: one gets standard discharge care, the other gets the digital system plus health coaching. The goal is to see if the digital approach reduces deaths and unplanned hospital visits over one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Digital out-of-hospital management platform (HeartMed-HF) with chip-implanted blood pressure monitor
What this could lead to
If it works, this could provide a practical way to monitor and support heart shock patients at home, potentially lowering deaths and hospital returns.
What could go wrong
This is an early-stage trial with 472 participants, so results may not apply to all patients. The digital system might not prevent serious complications, and technical issues could limit its use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Renmin Hospital of Wuhan University
RECRUITINGWuhan, Hubei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••